339 related articles for article (PubMed ID: 12910628)
1. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system].
Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S
J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628
[TBL] [Abstract][Full Text] [Related]
2. [The MMP/TIMP system in the nervous system].
Rivera S; Jourquin J; Ogier C; Bernard A; Charton G; Tremblay E; Khrestchatisky M
Med Sci (Paris); 2004 Jan; 20(1):55-60. PubMed ID: 14770364
[TBL] [Abstract][Full Text] [Related]
3. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura.
Mannello F
Clin Chim Acta; 2009 Nov; 409(1-2):1-3. PubMed ID: 19632213
[TBL] [Abstract][Full Text] [Related]
4. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes.
Sbai O; Ould-Yahoui A; Ferhat L; Gueye Y; Bernard A; Charrat E; Mehanna A; Risso JJ; Chauvin JP; Fenouillet E; Rivera S; Khrestchatisky M
Glia; 2010 Feb; 58(3):344-66. PubMed ID: 19780201
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
6. Complex roles of tissue inhibitors of metalloproteinases in cancer.
Jiang Y; Goldberg ID; Shi YE
Oncogene; 2002 Mar; 21(14):2245-52. PubMed ID: 11948407
[TBL] [Abstract][Full Text] [Related]
7. [Astrocytes, cells involved in neuro-immune interactions in the central nervous system].
Giraudon P; Malcus C; Chalon A; Vincent P; Khuth S; Bernard A; Belin MF
J Soc Biol; 2003; 197(2):103-12. PubMed ID: 12910625
[TBL] [Abstract][Full Text] [Related]
8. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
Haeusler G; Walter I; Helmreich M; Egerbacher M
Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
[TBL] [Abstract][Full Text] [Related]
9. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain.
Dzwonek J; Rylski M; Kaczmarek L
FEBS Lett; 2004 Jun; 567(1):129-35. PubMed ID: 15165905
[TBL] [Abstract][Full Text] [Related]
11. [Current data on metalloproteinases, obligatory partners of tumor progression].
Rémy L
Pathol Biol (Paris); 1997 Nov; 45(9):759-65. PubMed ID: 9538475
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez DE; Alonso DF; Yoshiji H; Thorgeirsson UP
Eur J Cell Biol; 1997 Oct; 74(2):111-22. PubMed ID: 9352216
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.
Benekareddy M; Mehrotra P; Kulkarni VA; Ramakrishnan P; Dias BG; Vaidya VA
Synapse; 2008 Aug; 62(8):590-600. PubMed ID: 18509851
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
Bode W; Maskos K
Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
[TBL] [Abstract][Full Text] [Related]
15. TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.
Vanhoutte D; Heymans S
J Mol Cell Cardiol; 2010 Mar; 48(3):445-53. PubMed ID: 19799912
[TBL] [Abstract][Full Text] [Related]
16. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease.
Ries C; Petrides PE
Biol Chem Hoppe Seyler; 1995 Jun; 376(6):345-55. PubMed ID: 7576228
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.
Toft-Hansen H; Babcock AA; Millward JM; Owens T
J Neuroinflammation; 2007 Sep; 4():24. PubMed ID: 17883829
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
19. The TIMPs tango with MMPs and more in the central nervous system.
Crocker SJ; Pagenstecher A; Campbell IL
J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
[TBL] [Abstract][Full Text] [Related]
20. Role of matrix metalloproteinases in delayed cortical responses after stroke.
Zhao BQ; Wang S; Kim HY; Storrie H; Rosen BR; Mooney DJ; Wang X; Lo EH
Nat Med; 2006 Apr; 12(4):441-5. PubMed ID: 16565723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
